• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在重症监护病房中识别潜在药物-药物相互作用的异质性:系统评价、批判性评估和报告建议。

Heterogeneity in the Identification of Potential Drug-Drug Interactions in the Intensive Care Unit: A Systematic Review, Critical Appraisal, and Reporting Recommendations.

机构信息

Amsterdam UMC (location AMC), Department of Medical Informatics, Amsterdam, The Netherlands.

Amsterdam UMC (location AMC), Department of Intensive Care Medicine, Amsterdam, The Netherlands.

出版信息

J Clin Pharmacol. 2022 Jun;62(6):706-720. doi: 10.1002/jcph.2020. Epub 2022 Feb 21.

DOI:10.1002/jcph.2020
PMID:34957573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9303874/
Abstract

Patients admitted to the intensive care unit (ICU) are frequently exposed to potential drug-drug interactions (pDDIs). However, reported frequencies of pDDIs in the ICU vary widely between studies. This can be partly explained by significant variation in their methodological approach. Insight into methodological choices affecting pDDI frequency would allow for improved comparison and synthesis of reported pDDI frequencies. This study aimed to evaluate the association between methodological choices and pDDI frequency and formulate reporting recommendations for pDDI frequency studies in the ICU. The MEDLINE database was searched to identify papers reporting pDDI frequency in ICU patients. For each paper, the pDDI frequency and methodological choices such as pDDI definition and pDDI knowledge base were extracted, and the risk of bias was assessed. Each paper was categorized as reporting a low, medium, or high pDDI frequency. We sought associations between methodological choices and pDDI frequency group. Based on this comparison, reporting recommendations were formulated. Analysis of methodological choices showed significant heterogeneity between studies, and 65% of the studies had a medium to high risk of bias. High risk of bias, small sample size, and use of drug prescriptions instead of administrations were related to a higher pDDI frequency. The findings of this review may support researchers in designing a reliable methodology assessing pDDI frequency in ICU patients. The reporting recommendations may contribute to standardization, comparison, and synthesis of pDDI frequency studies, ultimately improving knowledge about pDDIs in and outside the ICU setting.

摘要

患者入住重症监护病房 (ICU) 时常会接触到潜在的药物-药物相互作用 (pDDI)。然而,不同研究中 ICU 中 pDDI 的报告频率差异很大。这在一定程度上可以解释为其方法学方法存在显著差异。深入了解影响 pDDI 频率的方法学选择,将有助于更好地比较和综合报告的 pDDI 频率。本研究旨在评估方法学选择与 pDDI 频率之间的关系,并为 ICU 中 pDDI 频率研究制定报告建议。检索 MEDLINE 数据库以确定报告 ICU 患者 pDDI 频率的论文。对于每篇论文,提取了 pDDI 频率和方法学选择,如 pDDI 定义和 pDDI 知识库,并评估了偏倚风险。将每篇论文分为报告低、中、高 pDDI 频率的类别。我们研究了方法学选择与 pDDI 频率组之间的关联。基于此比较,制定了报告建议。对方法学选择的分析表明,研究之间存在显著的异质性,65%的研究存在中到高度偏倚风险。高偏倚风险、样本量小以及使用药物处方而非给药与更高的 pDDI 频率相关。本综述的结果可能支持研究人员设计一种可靠的方法来评估 ICU 患者的 pDDI 频率。报告建议可能有助于 pDDI 频率研究的标准化、比较和综合,最终提高对 ICU 内外 pDDI 的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a823/9303874/77d64c30e69d/JCPH-62-706-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a823/9303874/77d64c30e69d/JCPH-62-706-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a823/9303874/77d64c30e69d/JCPH-62-706-g001.jpg

相似文献

1
Heterogeneity in the Identification of Potential Drug-Drug Interactions in the Intensive Care Unit: A Systematic Review, Critical Appraisal, and Reporting Recommendations.在重症监护病房中识别潜在药物-药物相互作用的异质性:系统评价、批判性评估和报告建议。
J Clin Pharmacol. 2022 Jun;62(6):706-720. doi: 10.1002/jcph.2020. Epub 2022 Feb 21.
2
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
3
Melatonin for the promotion of sleep in adults in the intensive care unit.褪黑素用于促进重症监护病房成年患者的睡眠。
Cochrane Database Syst Rev. 2018 May 10;5(5):CD012455. doi: 10.1002/14651858.CD012455.pub2.
4
Interventions for interpersonal communication about end of life care between health practitioners and affected people.干预健康从业者与受影响者之间关于临终关怀的人际沟通。
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2.
5
The measurement and monitoring of surgical adverse events.手术不良事件的测量与监测
Health Technol Assess. 2001;5(22):1-194. doi: 10.3310/hta5220.
6
Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients.非 ICU 住院患者预防谵妄的非药物干预措施。
Cochrane Database Syst Rev. 2021 Nov 26;11(11):CD013307. doi: 10.1002/14651858.CD013307.pub3.
7
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
8
Early intervention (mobilization or active exercise) for critically ill adults in the intensive care unit.对重症监护病房中的成年重症患者进行早期干预(活动或主动锻炼)。
Cochrane Database Syst Rev. 2018 Mar 27;3(3):CD010754. doi: 10.1002/14651858.CD010754.pub2.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients.与标准护理相比,自动监测用于危重症患者脓毒症的早期检测
Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD012404. doi: 10.1002/14651858.CD012404.pub2.

引用本文的文献

1
Drug-drug-interactions in patients with atrial fibrillation admitted to the emergency department.急诊科收治的心房颤动患者的药物相互作用。
Front Pharmacol. 2024 Oct 15;15:1432713. doi: 10.3389/fphar.2024.1432713. eCollection 2024.
2
The Impact of Customized Screening Intervals on the Burden of Drug-Drug Interaction Alerts: An Interrupted Time Series Analysis.定制化筛查间隔对药物-药物相互作用警报负担的影响:一项中断时间序列分析。
J Med Syst. 2024 Sep 30;48(1):93. doi: 10.1007/s10916-024-02113-8.
3
Drug-Drug Interactions Involving High-Alert Medications that Lead to Interaction-Associated Symptoms in Pediatric Intensive Care Patients: A Retrospective Study.

本文引用的文献

1
Clinically relevant potential drug-drug interactions in intensive care patients: A large retrospective observational multicenter study.重症监护患者中具有临床意义的潜在药物-药物相互作用:一项大型回顾性观察性多中心研究。
J Crit Care. 2021 Apr;62:124-130. doi: 10.1016/j.jcrc.2020.11.020. Epub 2020 Dec 1.
2
Potential drug-drug interactions in ICU patients: a retrospective study.重症监护病房患者的潜在药物-药物相互作用:一项回顾性研究。
Drug Metab Pers Ther. 2020 Jul 20;35(3):dmpt-2020-0114. doi: 10.1515/dmpt-2020-0114.
3
Improving medication safety in the Intensive Care by identifying relevant drug-drug interactions - Results of a multicenter Delphi study.
药物-药物相互作用涉及高警示药物,可导致儿科重症监护病房患者出现与相互作用相关的症状:一项回顾性研究。
Paediatr Drugs. 2024 Sep;26(5):619-629. doi: 10.1007/s40272-024-00641-x. Epub 2024 Jul 4.
4
The Risk of Drug Interactions in Older Primary Care Patients after Hospital Discharge: The Role of Drug Reconciliation.老年初级保健患者出院后药物相互作用的风险:药物重整的作用。
Geriatrics (Basel). 2023 Dec 16;8(6):122. doi: 10.3390/geriatrics8060122.
5
The Use of Antibiotics and Antimicrobial Resistance in Veterinary Medicine, a Complex Phenomenon: A Narrative Review.兽医学中抗生素的使用与抗菌药物耐药性:一种复杂现象的叙述性综述
Antibiotics (Basel). 2023 Mar 1;12(3):487. doi: 10.3390/antibiotics12030487.
6
The Issue of Pharmacokinetic-Driven Drug-Drug Interactions of Antibiotics: A Narrative Review.抗生素药代动力学驱动的药物相互作用问题:一篇叙述性综述。
Antibiotics (Basel). 2022 Oct 13;11(10):1410. doi: 10.3390/antibiotics11101410.
通过识别相关药物-药物相互作用来提高重症监护中的药物安全性 - 一项多中心德尔菲研究的结果。
J Crit Care. 2020 Jun;57:134-140. doi: 10.1016/j.jcrc.2020.02.012. Epub 2020 Feb 21.
4
Identification and Assessment of Potential Drug-Drug Interactions in Intensive Care Unit Patients.重症监护病房患者潜在药物相互作用的识别与评估
Indian J Crit Care Med. 2019 Apr;23(4):170-174. doi: 10.5005/jp-journals-10071-23147.
5
Evaluation of Potential Drug-Drug Interactions in Adults in the Intensive Care Unit: A Systematic Review and Meta-Analysis.评估重症监护病房成人潜在药物-药物相互作用的系统评价和荟萃分析。
Drug Saf. 2019 Sep;42(9):1035-1044. doi: 10.1007/s40264-019-00829-y.
6
Epidemiology of potential drug-drug interactions in elderly population admitted to critical care units of Peshawar, Pakistan.巴基斯坦白沙瓦重症监护病房老年患者潜在药物相互作用的流行病学研究
BMC Pharmacol Toxicol. 2018 Dec 10;19(1):85. doi: 10.1186/s40360-018-0276-4.
7
Risk of potential drug-drug interactions in the cardiac intensive care units. A comparative analysis between 2 tertiary care hospitals.心脏重症监护病房中潜在药物相互作用的风险。两家三级护理医院之间的比较分析。
Saudi Med J. 2018 Dec;39(12):1207-1212. doi: 10.15537/smj.2018.12.23430.
8
The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE).观察性研究报告规范使用常规收集的健康数据在药物流行病学中的应用(RECORD-PE)声明。
BMJ. 2018 Nov 14;363:k3532. doi: 10.1136/bmj.k3532.
9
High prevalence of the risk factors for QT interval prolongation and associated drug-drug interactions in coronary care units.在冠心病监护病房中,QT 间期延长的风险因素和相关药物相互作用的流行率很高。
Postgrad Med. 2018 Nov;130(8):660-665. doi: 10.1080/00325481.2018.1516106. Epub 2018 Sep 5.
10
Preventable adverse drug events in critically ill HIV patients: Is the detection of potential drug-drug interactions a useful tool?重症HIV患者中可预防的药物不良事件:潜在药物相互作用的检测是一种有用的工具吗?
Clinics (Sao Paulo). 2018 Feb 19;73:e148. doi: 10.6061/clinics/2018/e148.